Hapten-enhanced overall survival time in advanced hepatocellular carcinoma by ultro-minimum incision personalized intratumoral chemoimmunotherapy

PURPOSE: To compare the therapeutic effects of ultra-minimum incision personalized intratumoral chemoimmunotherapy (UMIPIC) with intratumoral chemotherapy (ITCT) in the treatment of advanced hepatocellular carcinomas and to analyze the effect of hapten as an immune booster. MATERIALS AND METHODS: Pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Feng, Jing, Peng, Liu, Jian, Lu, Yuanfei, Zhang, Peicheng, Han, Wei, Liu, Guoliang, Ru, Ning, Cui, Guanghui, Sun, Chenglin, Che, Yebing, Zhang, Huaming, Hu, Qnglong, Wang, Huan-You, Wu, Yingli, Guan, Changjiang, Fu, Qiang, Ma, Zhenlu, Yu, Baofa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918285/
https://www.ncbi.nlm.nih.gov/pubmed/27508195
http://dx.doi.org/10.2147/JHC.S80756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918285/
https://www.ncbi.nlm.nih.gov/pubmed/27508195
http://dx.doi.org/10.2147/JHC.S80756

Ejemplares similares